Clinical Trial Update: A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating strategies to improve success of treatment discontinuation in buprenorphine responders for opioid-use disorder; study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid-use Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-06-21